Patients with cutaneous squamous cell carcinoma (cSCC), globally the second-most common form of skin cancer, frequently develop multiple primary tumors either simultaneously or during follow-up.
1 The reported risk of metastasis from cSCC varies, particularly between hospital-based
2-6 and population-based studies.
7-9 Organ transplant recipients (OTRs) have a very high risk of developing cSCC
10-13 and seem to have a greater risk of metastasis from cSCC than immunocompetent patients.
14 Studies on the risk of disease-specific death from cSCC, however, are limited both in immunocompetent and immunosuppressed patients.
15,16 To increase knowledge on the epidemiology and clinical course of cSCC, we studied the occurrence of a second cSCC, metastasis, and death from cSCC in non-OTRs and OTRs, using population-based data from national registries that span more than 5 decades.